BioVaxys Technology Corp. (BIOV.CN)
CAD 0.06
(10.0%)
CAD 0.06
(10.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -7.68 Million CAD | 60.29% |
| 2022 | -19.35 Million CAD | -199.01% |
| 2021 | -6.47 Million CAD | -449.31% |
| 2020 | -1.17 Million CAD | -411.67% |
| 2019 | -230.33 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 518.04 Thousand CAD | 114.13% |
| 2024 Q3 | -1.18 Million CAD | -118.75% |
| 2024 Q2 | -542.38 Thousand CAD | -204.7% |
| 2023 Q2 | -3.07 Million CAD | -195.5% |
| 2023 Q1 | -1.04 Million CAD | 93.56% |
| 2023 FY | -7.68 Million CAD | 60.29% |
| 2023 Q4 | -3.66 Million CAD | -132.74% |
| 2023 Q3 | -1.57 Million CAD | 48.79% |
| 2022 Q1 | -1.21 Million CAD | 51.93% |
| 2022 Q4 | -16.16 Million CAD | -1674.29% |
| 2022 FY | -19.35 Million CAD | -199.01% |
| 2022 Q3 | -911.09 Thousand CAD | 14.92% |
| 2022 Q2 | -1.07 Million CAD | 11.59% |
| 2021 Q4 | -2.51 Million CAD | -178.4% |
| 2021 FY | -6.47 Million CAD | -449.31% |
| 2021 Q1 | -1.53 Million CAD | -87.39% |
| 2021 Q3 | -905.08 Thousand CAD | 39.49% |
| 2021 Q2 | -1.49 Million CAD | 2.71% |
| 2020 Q2 | -65.42 Thousand CAD | -94.65% |
| 2020 Q1 | -33.61 Thousand CAD | 50.5% |
| 2020 FY | -1.17 Million CAD | -411.67% |
| 2020 Q4 | -820.42 Thousand CAD | -221.92% |
| 2020 Q3 | -254.85 Thousand CAD | -289.54% |
| 2019 Q3 | -37.82 Thousand CAD | 35.84% |
| 2019 Q1 | -65.44 Thousand CAD | 49.76% |
| 2019 Q4 | -67.9 Thousand CAD | -79.53% |
| 2019 Q2 | -58.95 Thousand CAD | 9.92% |
| 2019 FY | -230.33 Thousand CAD | 0.0% |
| 2018 Q4 | -130.25 Thousand CAD | -320.64% |
| 2018 Q3 | -30.96 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -6.78 Million CAD | -13.362% |
| Asep Medical Holdings Inc | -8.22 Million CAD | 6.564% |
| BetterLife Pharma Inc. | -2.88 Million CAD | -166.086% |
| ChitogenX Inc. | -1.55 Million CAD | -394.679% |
| Rapid Dose Therapeutics Corp. | -4.3 Million CAD | -78.505% |
| Defence Therapeutics Inc. | -13.19 Million CAD | 41.732% |
| Entheon Biomedical Corp. | -300 Thousand CAD | -2462.43% |
| Gemina Laboratories Ltd. | -5.21 Million CAD | -47.357% |
| Glow Lifetech Corp. | -1.64 Million CAD | -367.14% |
| Lexston Life Sciences Corp. | -867.71 Thousand CAD | -785.929% |
| Pharmala Biotech Holdings Inc. | -779.81 Thousand CAD | -885.79% |
| Doseology Sciences Inc. | -339.84 Thousand CAD | -2161.987% |
| MYND Life Sciences Inc. | -1.51 Million CAD | -406.458% |
| Nova Mentis Life Science Corp. | -1.22 Million CAD | -527.832% |
| PharmaTher Holdings Ltd. | -3.11 Million CAD | -146.757% |
| PreveCeutical Medical Inc. | -1.27 Million CAD | -503.177% |
| Telescope Innovations Corp. | -5.72 Million CAD | -34.223% |